GLP-1 drugs like Ozempic or Zepbound may not affect risk of 13 obesity-related cancers
Despite previous excitement around a potential link between GLP-1 drugs and a reduced risk of cancer, new research suggests the...
GLP1
WHO issues global guideline on the use of GLP-1 medicines in treating obesity
To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health Organization (WHO)...
Targeted solutions for women’s health, longevity and GLP-1 complements
At this year’s SupplySide Global trade show in Las Vegas, Nevada, US, exhibitors highlighted targeted women’s health solutions, solutions to...
